Biohit oyj’s annual general meeting 2020

Report this content

Biohit Oyj 

Stock Exchange Release 


Biohit takes the threat of the Corona virus extremely seriously as a company which promotes healthy of the people. Biohit has, based on the development of the situation and the announcement by the Finnish Government decided to convene the Annual General Meeting at a later stage when Corona virus does not anymore cause any healthyrisks for for the meeting participants.  

Helsinki, 27 March 2020

Biohit Oyj
Board of Directors

Additional information:

CEO Semi Korpela, Biohit Oyj
tel. +358 9 773 861



Biohit in brief

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group.